Fatiabgen.Co.,Ltd

4 employees

Fatiabgen is a biopharmaceutical company that develops monoclonal antibody-based therapy for the treatment of infectious diseases.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

biomaker

immunotoxin drug

Stem cell

Cancer therapy

indication

antibody drug

Liver cancer

nanobody

immunotoxins

ADC

Single domain antibody

Toxin Library

pancreatic cancer

Breast cancer

Biopharma

healthcare

Biliary tract cancer

Organoid

Autoimmune Diseases

Lung Cancer

peptide toxin

Medical

2020

Fatiabgen.Co.,Ltd raised undisclosed on January 1, 2023

Investors: UTC Investment Co.,Ltd.